FDA issued a warning letter to Abbott citing multiple quality-system violations for its FreeStyle Libre continuous glucose monitor.
Longevity News
Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose moni...
Source: FierceBiotech - Medtech • Published: 20 Feb 2026, 04:51
Continue exploring
Related longevity signals
Nature - BiotechnologyGlucose-responsive probiotics for glycaemic modulation in mice and monkeysAn article about engineered oral probiotics that sense high glucose and trigger therapeutic responses; it previews a preclinical study exploring this programmable living‑drug approach.Fight Aging!Bacterial Lipoic Acid Protein Ligase A Improves Mammalian Mitochondrial Function and HealthThis article previews research on using a bacterial enzyme to boost mitochondrial protein modification and overall cellular energy, framed as a potential metabolic-enhancing therapy. It invites readers curious about cross-species gene therapy approaches aimed at improving healthspan and age-related function.Nature - BiotechnologySEQURNA enhances FLASH-seq gene detection while eliminating DTT dependenceSEQURNA-focused methods article presenting a comparative benchmark of a synthetic thermostable RNase inhibitor for improved single-cell, full-length RNA-seq workflows.Longevity TechnologyClaremedica’s digital test finds 90% of new dementia cases earlyA report on a primary care group’s adoption of a digital cognitive assessment and what readers will learn about its implementation and uptake.